Latest Share Chat

REMOVE ADS

Hikma Pharmaceuticals Share News (HIK)

Hikma Pharmaceuticals Information

Share Price Information for Hikma Pharmaceuticals (HIK)

Share Price is delayed by 15 minutes

Get Live Data

1,540.00 9.00 (0.59%)

Bid:

1,535.00

Ask:

1,536.00

Spread: 1.00 (0.065%)

Market Cap: £3.24b

Last checked at -

Intraday Hikma Pharmaceuticals Share Chart

REMOVE ADS

Wednesday broker round-up

Wed, 16th Mar 2016 15:55

(ShareCast News) - Hikma Pharmaceuticals: Panmure Gordon upgrades to buy with a target price of 2120p.Greggs: Berenberg upgrades to hold, 1020p target.Firestone Diamonds: Panmure Gordon reiterates buy with a target price of 27p and Finncap stays at buy with a target price of 51p.Cairn Energy: Canaccord downgrades to hold with a target price of 210p and Credit Suisse reiterates neutral with a target price of 190p and Citigroup stays at neutral.Derwent London: Exane BNP Paribas upgrades to neutral a target of 3430p.Antofagasta: JP Morgan reiterates overweight, 600p target, UBS keeps at sell with a target of 450p and Citigroup upgrades to buy.National Express: Jefferies reiterates buy with a target price of 370p.Sainsbury: Nomura maintains neutral with a 280p target and HSBC stays at reduce with a 200p target.Ocado: Goldman Sachs keeps at buy and with a target of 690p.Wolseley: JP Morgan reiterates overweight, 4300p target.